Clinical Trial Update: Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical study exploring pharmacologic strategies to prevent recurrence of primary sclerosing cholangitis after liver transplantation, currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Snippet

Sponsor: Mayo Clinic | Conditions: Primary Sclerosing Cholangitis, Liver Transplant, Complications | Phase 2 | Status: RECRUITING